Trials / Completed
CompletedNCT01244750
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Studying Interventions for Managing Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,494 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to better understand the use of tyrosine kinase inhibitors (TKI) in patients newly diagnosed with CML and their quality of life in a real-world setting.
Detailed description
Time Perspective : Most patients are expected to be a mix of retrospective and prospective data collection. Patients can be enrolled after their study index date (retrospective component) and have to be followed until 5 years from study index date are complete (time between enrollment and 5 year follow-up is the prospective component)
Conditions
Timeline
- Start date
- 2010-12-02
- Primary completion
- 2020-01-08
- Completion
- 2020-01-08
- First posted
- 2010-11-19
- Last updated
- 2022-06-30
Locations
214 sites across 8 countries: United States, France, Germany, Italy, Netherlands, Puerto Rico, Russia, Spain
Source: ClinicalTrials.gov record NCT01244750. Inclusion in this directory is not an endorsement.